← Eichor
Study identifier: NCT06387017 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway

Condition: Smoking-related Pathology · Atheroma · Non-progressive Cancer > 5 Years  ·  Sponsor: Assistance Publique Hopitaux De Marseille

PhaseNA
Planned participants750
Who can joinAll sexes, 45 Years to 80 Years
Healthy volunteersNo

About this study

Interventional study with minimal risks and constraints, with evaluation of the incidence of lung cancers by low-dose thoracic CT scan without injection of contrast medium, of the immunological, inflammatory and metabolic blood profile and of the microbiota; systematic proposal of smoking cessation for active smokers or assistance in maintaining cessation.

This description comes directly from the study's public registry record.

Talk to the study team

Amandine ROLLAND-BRUN  ·  491381245  ·  amandine.rolland@ap-hm.fr

David BOULATE  ·  david.boulate@ap-hm.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Assistance Publique Hopitaux de MarseilleMarseille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06387017